D. De-l-'osteoporose:-mythes and .. Statistiques-ou-realites-cliniques-?..-la-fracture, 68 3.1. Diagnostic positif, p.68

D. Recueil-des, 84 4.2.3, p.86

M. Rousière, The importance of taking care of osteoporosis. Presse Médicale Paris Fr, pp.900-909, 1983.

D. Marshall, O. Johnell, and H. Wedel, Meta-analysis of how well measures of bone mineral density predict occurrence of osteoporotic fractures, BMJ, vol.312, issue.7041, pp.1254-1259, 1996.
DOI : 10.1136/bmj.312.7041.1254

J. Kanis, L. Melton, C. Christiansen, C. Johnston, and N. Khaltaev, The diagnosis of osteoporosis, Journal of Bone and Mineral Research, vol.36, issue.1, pp.1137-1141, 1994.
DOI : 10.1097/00003086-197007000-00029

C. Roux, V. Breuil, P. Orcel, and P. Fardellone, Diagnosis of osteoporosis, Rev Prat, vol.54, pp.2107-2119, 2004.

T. Funck-brentano, P. Orcel, and . Ostéoporose, Ost??oporose, EMC - Trait?? de m??decine AKOS, vol.5, issue.3, pp.1-12, 2010.
DOI : 10.1016/S1634-6939(10)39647-5

B. Troen, Molecular mechanisms underlying osteoclast formation and activation, Experimental Gerontology, vol.38, issue.6, pp.605-614, 2003.
DOI : 10.1016/S0531-5565(03)00069-X

R. Pacifici, Mechanisms of estrogen action in bone, In: Bilezikian J. Principles of bone biology, pp.693-706, 2002.

M. Beers, R. Berkow, and . ???????????????????????????????????, Paris: ???????? ????, pp.466-470, 2000.

G. Weryha and M. Agopianz, Effets osseux de la contraception orale: mythes et réalités. Correspondances en Métabolismes Hormones Diabètes et Nutrition, pp.5-6161, 2012.

G. Dubourg and P. Orcel, Ostéoporose Encycl Méd Chir, 1998.

G. Mundy, Remodelage osseux et mécanismes de la perte osseuse dans l'ostéoporose. In: Meunier PJ. Ostéoporose: progrès dans le diagnostic et la prise en charge, pp.17-36, 1998.

M. Cohen-solal, M. P. , D. Vernejoul, and M. , Pathophysiology and genetics of osteoporosis, Ann Médecine Interne, vol.151, issue.5, pp.373-379, 2000.

I. Tresguerres, F. Tamimi, H. Eimar, J. Barralet, S. Prieto et al., Melatonin Dietary Supplement as an Anti-Aging Therapy for Age-Related Bone Loss, Rejuvenation Research, vol.17, issue.4, 2014.
DOI : 10.1089/rej.2013.1542

P. Baldock and J. Eisman, Genetic determinants of bone mass, Current Opinion in Rheumatology, vol.16, issue.4, pp.450-456, 2004.
DOI : 10.1097/01.moo.0000127828.34643.b4

R. Levasseur, D. Lacombe, and M. De-vernejoul, LRP5 : le g??ne mut?? dans le syndrome d'ost??oporose avec pseudogliome et le ph??notype de masse osseuse ??lev??e, Revue du Rhumatisme, vol.72, issue.5, pp.388-396, 2005.
DOI : 10.1016/j.rhum.2004.10.009

J. Kanis and C. Glüer, An Update on the Diagnosis and Assessment of Osteoporosis with Densitometry, Osteoporosis International, vol.11, issue.3, pp.192-202, 2000.
DOI : 10.1007/s001980050281

H. Osteodensitometrie, Absorptiométrie osseuse) sur 2 sites, par méthode biphotonique Disponible sur, 2006.

E. Sornay-rendu, F. Munoz, P. Garnero, F. Duboeuf, and P. Delmas, Identification of Osteopenic Women at High Risk of Fracture: The OFELY Study, Journal of Bone and Mineral Research, vol.18, issue.Suppl 6, pp.1813-1819, 2005.
DOI : 10.1007/s001980050172

M. Maravic, L. Bihan, C. Landais, P. Fardellone, and P. , Incidence and cost of osteoporotic fractures in France during 2001. A methodological approach by the national hospital database, Osteoporosis International, vol.13, issue.12, pp.1475-1480, 2005.
DOI : 10.1016/S0020-1383(99)00248-X

F. Grados, C. Marcelli, P. Dargent-molina, C. Roux, J. Vergnol et al., Prevalence of vertebral fractures in French women older than 75 years from the EPIDOS study, Bone, vol.34, issue.2, pp.362-367, 2004.
DOI : 10.1016/j.bone.2003.11.008

E. Lespessailles, F. Cotté, C. Roux, P. Fardellone, F. Mercier et al., Prevalence and features of osteoporosis in the French general population: The Instant study, Joint Bone Spine, vol.76, issue.4, pp.394-400, 2009.
DOI : 10.1016/j.jbspin.2008.10.008

F. Blotman, B. Cortet, P. Hilliquin, B. Avouac, F. Allaert et al., Characterisation of Patients with Postmenopausal Osteoporosis in French Primary Healthcare, Drugs & Aging, vol.17, issue.6, pp.603-614, 2007.
DOI : 10.2165/00002512-200724070-00007

D. Briançon, J. De-gaudemar, and R. Forestier, Management of osteoporosis in women with peripheral osteoporotic fractures after 50 years of age: a study of practices, Joint Bone Spine, vol.71, issue.2, pp.128-130, 2004.
DOI : 10.1016/S1297-319X(03)00060-5

. Qu, est-ce que l'ostéoporose? Disponible sur

A. Tenenhouse, L. Joseph, N. Kreiger, S. Poliquin, T. Murray et al., Estimation of the Prevalence of Low Bone Density in Canadian Women and Men Using a Population-Specific DXA Reference Standard: The Canadian Multicentre Osteoporosis Study (CaMos), Osteoporosis International, vol.11, issue.10, pp.897-904, 2000.
DOI : 10.1007/s001980070050

M. Iki, Epidemiology of osteoporosis in Japan, Clin Calcium, vol.22, issue.6, pp.797-803, 2012.

L. Melton, E. Chrischilles, C. Cooper, A. Lane, B. Riggs et al., How Many Women Have Osteoporosis?, Journal of Bone and Mineral Research, vol.70, issue.5, pp.1005-1010, 1992.
DOI : 10.1161/01.CIR.70.3.345

URL : http://onlinelibrary.wiley.com/doi/10.1359/jbmr.2005.20.5.886/pdf

K. Briot, B. Cortet, F. Trémollières, B. Sutter, T. Thomas et al., Male osteoporosis: Diagnosis and fracture risk evaluation, Joint Bone Spine, vol.76, issue.2, pp.129-133, 2009.
DOI : 10.1016/j.jbspin.2008.07.014

URL : https://hal.archives-ouvertes.fr/inserm-00395613

A. Schott, Données épidémiologiques françaises sur l'ostéoporose: comment interpréter ces résultats? La Lettre du Rhumatologue, Juin, vol.353, p.34, 2009.

J. Féron, T. Thomas, C. Roux, and J. Puget, L???ost??oporose et l???orthop??diste en 2007, Revue de Chirurgie Orthop??dique et R??paratrice de l'Appareil Moteur, vol.94, issue.6, pp.99-107, 2008.
DOI : 10.1016/j.rco.2008.06.007

P. Dargent-molina, Epidemiology and risk factors for osteoporosis. Rev Médecine Interne Fondée Par Société Natl Francaise Médecine Interne, pp.517-525, 2004.

O. Johnell and J. Kanis, Epidemiology of osteoporotic fractures, Osteoporosis International, vol.15, issue.S02, pp.3-7, 2005.
DOI : 10.1007/s00198-004-1702-6

J. Cauley, N. Wampler, J. Barnhart, L. Wu, M. Allison et al., Incidence of fractures compared to cardiovascular disease and breast cancer: the Women???s Health Initiative Observational Study, Osteoporosis International, vol.8, issue.1, pp.1717-1723, 2008.
DOI : 10.1007/s00198-008-0634-y

P. Orcel and T. Funck-brentano, Medical management following an osteoporotic fracture, Orthopaedics & Traumatology: Surgery & Research, vol.97, issue.8, pp.860-869, 2011.
DOI : 10.1016/j.otsr.2011.10.002

URL : https://doi.org/10.1016/j.otsr.2011.10.002

E. Bass, D. French, D. Bradham, and L. Rubenstein, Risk-Adjusted Mortality Rates of Elderly Veterans with Hip Fractures, Annals of Epidemiology, vol.17, issue.7, pp.514-519, 2007.
DOI : 10.1016/j.annepidem.2006.12.004

P. Bonnevialle and J. Féron, Les fractures des sujets âgés de plus de 80 ans, Symposium SOFCOT, issue.89, pp.2-129, 2002.

C. Cooper, G. Campion, and L. Melton, Hip fractures in the elderly: A world-wide projection, Osteoporosis International, vol.300, issue.6, pp.285-289, 1992.
DOI : 10.1007/BF01623184

M. Maravic, P. Taupin, P. Landais, and C. Roux, Change in hip fracture incidence over the last 6 years in France, Osteoporosis International, vol.20, issue.3, pp.797-801, 2011.
DOI : 10.1007/s00198-008-0687-y

. Loi, relative à la politique de santé publique, Disponible sur, 2004.

O. European-prospective, . Study, . Epos, . Group, D. Felsenberg et al., Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS), J Bone Miner Res Off J Am Soc Bone Miner Res, vol.17, issue.4, pp.716-724, 2002.

O. Neill, T. Felsenberg, D. Varlow, J. Cooper, C. Kanis et al., The prevalence of vertebral deformity in European men and women: The european vertebral osteoporosis study, Journal of Bone and Mineral Research, vol.7, issue.7, pp.1010-1018, 1996.
DOI : 10.1097/00003086-196600450-00005

A. Kwok, J. Leung, A. Chan, B. Au, E. Lau et al., Prevalence of vertebral fracture in Asian men and women: Comparison between Hong Kong, Thailand, Indonesia and Japan, Public Health, vol.126, issue.6, pp.523-531, 2012.
DOI : 10.1016/j.puhe.2012.03.002

S. Gehlbach, C. Bigelow, M. Heimisdottir, S. May, M. Walker et al., Recognition of Vertebral Fracture in a Clinical Setting, Osteoporosis International, vol.11, issue.7, pp.577-582, 2000.
DOI : 10.1007/s001980070078

J. Laredo, K. Lakhdari, L. Bellaïche, B. Hamze, P. Janklewicz et al., Acute vertebral collapse: CT findings in benign and malignant nontraumatic cases., Radiology, vol.194, issue.1, pp.41-48, 1995.
DOI : 10.1148/radiology.194.1.7997579

K. Briot, E. Legrand, D. Pouchain, S. Monnier, and C. Roux, Accuracy of patient-reported height loss and risk factors for height loss among postmenopausal women, Canadian Medical Association Journal, vol.182, issue.6, pp.558-562, 2010.
DOI : 10.1503/cmaj.090710

C. Klotzbuecher, P. Ross, P. Landsman, T. Abbott, and M. Berger, Patients with Prior Fractures Have an Increased Risk of Future Fractures: A Summary of the Literature and Statistical Synthesis, Journal of Bone and Mineral Research, vol.318, issue.Suppl 5, pp.721-739, 2000.
DOI : 10.1136/bmj.318.7182.500

D. Black, N. Arden, L. Palermo, J. Pearson, and S. Cummings, Prevalent Vertebral Deformities Predict Hip Fractures and New Vertebral Deformities but Not Wrist Fractures, Journal of Bone and Mineral Research, vol.7, issue.Suppl 4, pp.821-828, 1999.
DOI : 10.1136/bmj.312.7041.1254

URL : http://onlinelibrary.wiley.com/doi/10.1359/jbmr.1999.14.5.821/pdf

T. Van-geel, S. Van-helden, P. Geusens, B. Winkens, and G. Dinant, Clinical subsequent fractures cluster in time after first fractures, Annals of the Rheumatic Diseases, vol.68, issue.1, pp.99-102, 2009.
DOI : 10.1136/ard.2008.092775

L. Giangregorio and W. Leslie, Time since prior fracture is a risk modifier for 10-year osteoporotic fractures, Journal of Bone and Mineral Research, vol.32, issue.6, pp.1400-1405, 2010.
DOI : 10.1503/cmaj.081720

P. Dargent-molina, F. Favier, H. Grandjean, C. Baudoin, A. Schott et al., Fall-related factors and risk of hip fracture: the EPIDOS prospective study, The Lancet, vol.348, issue.9021, pp.145-149, 1996.
DOI : 10.1016/S0140-6736(96)01440-7

M. Stevens, C. Holman, and N. Bennett, Preventing Falls in Older People: Impact of an Intervention to Reduce Environmental Hazards in the Home, Journal of the American Geriatrics Society, vol.27, issue.Suppl., pp.1442-1447, 2001.
DOI : 10.1016/0001-4575(95)00016-S

K. Briot, B. Cortet, T. Thomas, M. Audran, H. Blain et al., 2012 update of French guidelines for the pharmacological treatment of postmenopausal osteoporosis, Joint Bone Spine, vol.79, issue.3, pp.304-313, 2012.
DOI : 10.1016/j.jbspin.2012.02.014

S. Buatois and A. Bénétos, Mise en place d???une ??chelle clinique simple pour ??valuer le risque de chutes r??p??t??es chez les seniors, Disponible sur, 2011.
DOI : 10.1016/S1779-0123(11)75077-X

J. Kanis, Diagnosis of osteoporosis and assessment of fracture risk, The Lancet, vol.359, issue.9321, pp.1929-1936, 2002.
DOI : 10.1016/S0140-6736(02)08761-5

R. Chapurlat, Quand traiter une ostéoporose sans fracture? Rev Prat, pp.199-203, 2012.

S. Schuit, M. Van-der-klift, A. Weel, C. De-laet, H. Burger et al., Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study, Bone, vol.34, issue.1, pp.195-202, 2004.
DOI : 10.1016/j.bone.2003.10.001

E. Lochmüller, P. Miller, D. Bürklein, U. Wehr, W. Rambeck et al., In Situ Femoral Dual-Energy X-ray Absorptiometry Related to Ash Weight, Bone Size and Density, and its Relationship with Mechanical Failure Loads of the Proximal Femur, Osteoporosis International, vol.11, issue.4, pp.361-367, 2000.
DOI : 10.1007/s001980070126

J. Kanis, O. Johnell, A. Oden, H. Johansson, and E. Mccloskey, FRAX??? and the assessment of fracture probability in men and women from the UK, Osteoporosis International, vol.17, issue.Suppl 2, pp.385-397, 2008.
DOI : 10.1093/qjmed/hci029

C. Couris, R. Chapurlat, J. Kanis, H. Johansson, N. Burlet et al., FRAX?? probabilities and risk of major osteoporotic fracture in France, Osteoporosis International, vol.18, issue.3, pp.2321-2327, 2012.
DOI : 10.1007/s00198-006-0245-4

B. Cortet, Ostéoporose: quelle place pour le Frax? Rev Prat Med gen, pp.229-230, 2011.

K. Ensrud, L. Lui, B. Taylor, J. Schousboe, M. Donaldson et al., A Comparison of Prediction Models for Fractures in Older Women, Archives of Internal Medicine, vol.169, issue.22, pp.2087-2094, 2009.
DOI : 10.1001/archinternmed.2009.404

M. Donaldson, L. Palermo, J. Schousboe, K. Ensrud, M. Hochberg et al., FRAX and Risk of Vertebral Fractures: The Fracture Intervention Trial, Journal of Bone and Mineral Research, vol.24, issue.11, pp.1793-1799, 2009.
DOI : 10.1359/jbmr.090511

E. Sornay-rendu, F. Munoz, P. Delmas, and R. Chapurlat, The FRAX tool in French women: How well does it describe the real incidence of fracture in the OFELY cohort, Journal of Bone and Mineral Research, vol.21, issue.10, pp.2101-2107, 2010.
DOI : 10.1002/jbmr.106

F. Trémollieres, J. Pouillès, N. Drewniak, J. Laparra, C. Ribot et al., Fracture risk prediction using BMD and clinical risk factors in early postmenopausal women: Sensitivity of the WHO FRAX tool, Journal of Bone and Mineral Research, vol.355, issue.5, pp.1002-1009, 2010.
DOI : 10.1056/NEJMp068249

C. Roux and T. Thomas, Optimal use of FRAX??, Joint Bone Spine, vol.76, issue.1, pp.1-3, 2009.
DOI : 10.1016/j.jbspin.2008.11.001

URL : https://hal.archives-ouvertes.fr/inserm-00395611

C. Roux, Nouvelles recommandations thérapeutiques de l'ostéoporose postménopausique: qu'apportent-elles? Réalités en Rhumato, pp.13-16, 2012.

P. Fardellone, La supplémentation vitamino-calcique mode d'emploi. Repères en gériatrie, pp.33-37, 2010.

J. Bonjour, A. Carrie, S. Ferrari, H. Clavien, D. Slosman et al., Calcium-enriched foods and bone mass growth in prepubertal girls: a randomized, double-blind

V. Breuil, L. Euller-ziegler, X. Hébuterne, A. E. Raynaud-simon, A. Vellas et al., Métabolisme phospho-calcique et besoins spécifiques de la personne âgée Traité de nutrition de la personne âgée, 2009.

X. Deprez and P. Fardellone, Nonpharmacological prevention of osteoporotic fractures, Joint Bone Spine, vol.70, issue.6, pp.448-457, 2003.
DOI : 10.1016/j.jbspin.2003.09.004

Y. Yang, J. Lewis, S. Epstein, and D. Metz, Long-term Proton Pump Inhibitor Therapy and Risk of Hip Fracture, JAMA, vol.296, issue.24, pp.2947-2953, 2006.
DOI : 10.1001/jama.296.24.2947

M. Bolland, A. Avenell, J. Baron, A. Grey, G. Maclennan et al., Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis, BMJ, vol.341, issue.jul29 1, p.3691, 2010.
DOI : 10.1136/bmj.c3691

I. Reid, M. Bolland, P. Sambrook, and A. Grey, Calcium supplementation: Balancing the cardiovascular risks, Maturitas, vol.69, issue.4, pp.289-295, 2011.
DOI : 10.1016/j.maturitas.2011.04.014

M. Holick, Vitamin D Deficiency, New England Journal of Medicine, vol.357, issue.3, pp.266-281, 2007.
DOI : 10.1056/NEJMra070553

M. Audran and K. Briot, Critical reappraisal of vitamin D deficiency, Joint Bone Spine, vol.77, issue.2, pp.115-119, 2010.
DOI : 10.1016/j.jbspin.2009.12.003

H. Bischoff-ferrari, A. Shao, B. Dawson-hughes, J. Hathcock, E. Giovannucci et al., Benefit???risk assessment of vitamin D supplementation, Osteoporosis International, vol.24, issue.5, pp.1121-1132, 2010.
DOI : 10.1080/07315724.2003.10719287

V. Breuil, Precautions before starting a treatment for osteoporosis, Rev Prat, vol.62, issue.2, pp.204-208, 2012.

M. Mcclung, E. Lewiecki, S. Cohen, M. Bolognese, G. Woodson et al., Denosumab in Postmenopausal Women with Low Bone Mineral Density, New England Journal of Medicine, vol.354, issue.8, pp.821-831, 2006.
DOI : 10.1056/NEJMoa044459

C. Benhamou, B. Souberbielle, B. Cortet, P. Fardellone, J. Gauvain et al., La vitamine D chez l'adulte: recommandations du GRIO, Presse Med, issue.40, pp.673-682, 2011.

J. Bonjour, Dietary Protein: An Essential Nutrient For Bone Health, Journal of the American College of Nutrition, vol.73, issue.sup6, 2005.
DOI : 10.1016/S0140-6736(99)05463-X

J. Kanis, H. Johansson, O. Johnell, A. Oden, D. Laet et al., Alcohol intake as a risk factor for fracture, Osteoporosis International, vol.13, issue.7, pp.737-742, 2005.
DOI : 10.1359/jbmr.2000.15.4.721

P. Wong, J. Christie, and J. Wark, The effects of smoking on bone health, Clinical Science, vol.113, issue.5, pp.233-241, 1979.
DOI : 10.1042/CS20060173

J. Beaudreuil, Nonpharmacological treatments for osteoporosis Ann Réadapt Médecine Phys Rev Sci Société Fr Rééduc Fonct Réadapt Médecine Phys, pp.581-588, 2006.

C. Lock, J. Lecouturier, J. Mason, and H. Dickinson, Lifestyle interventions to prevent osteoporotic fractures: a systematic review, Osteoporosis International, vol.359, issue.1, pp.20-28, 2006.
DOI : 10.1212/01.WNL.0000078892.24356.90

M. Pfeifer, M. Sinaki, P. Geusens, S. Boonen, E. Preisinger et al., Musculoskeletal Rehabilitation in Osteoporosis: A Review, Journal of Bone and Mineral Research, vol.21, issue.8, pp.1208-1214, 2004.
DOI : 10.1016/S8756-3282(97)00082-3

H. Prévention, diagnostic et traitement de l'ostéoporose. Note de synthèse Disponible sur http, 2006.

C. Smith, A Systematic Review of Healthcare Professional???Led Education for Patients With Osteoporosis or Those at High Risk for the Disease, Orthopaedic Nursing, vol.29, issue.2, pp.119-132, 2010.
DOI : 10.1097/NOR.0b013e3181d24414

E. Siris, S. Harris, C. Rosen, C. Barr, J. Arvesen et al., Adherence to Bisphosphonate Therapy and Fracture Rates in Osteoporotic Women: Relationship to Vertebral and Nonvertebral Fractures From 2 US Claims Databases, Mayo Clinic Proceedings, vol.81, issue.8, pp.1013-1022, 2006.
DOI : 10.4065/81.8.1013

E. Shane, D. Burr, B. Abrahamsen, R. Adler, T. Brown et al., Atypical Subtrochanteric and Diaphyseal Femoral Fractures: Second Report of a Task Force of the American Society for Bone and Mineral Research, Journal of Bone and Mineral Research, vol.52, issue.3, pp.1-23, 2014.
DOI : 10.1016/j.bone.2012.10.006

J. Schilcher, K. Michaëlsson, and P. Aspenberg, Bisphosphonate Use and Atypical Fractures of the Femoral Shaft, New England Journal of Medicine, vol.364, issue.18, pp.1728-1737, 2011.
DOI : 10.1056/NEJMoa1010650

M. Rousière, M. Laxenaire, and P. Orcel, Effets secondaires des bisphosphonates. L'Actualité Rhumatologique, 2008.

S. Silverman and R. Landesberg, Osteonecrosis of the Jaw and the Role of Bisphosphonates: A Critical Review, The American Journal of Medicine, vol.122, issue.2, pp.33-45, 2009.
DOI : 10.1016/j.amjmed.2008.12.005

Y. Loke, V. Jeevanantham, and S. Singh, Bisphosphonates and Atrial Fibrillation, Drug Safety, vol.55, issue.4, pp.219-228, 2009.
DOI : 10.7326/0003-4819-130-4-199902160-00008

C. Garwood, K. Van-schepen, R. Mcdonough, and A. Sullivan, Increased Thyroid-Stimulating Hormone Levels Associated with Concomitant Administration of Levothyroxine and Raloxifene, Pharmacotherapy, vol.8, issue.6, pp.881-885, 2006.
DOI : 10.4158/1934-2403-8.6.457

B. Laviolle, Pharmacologie de l'ostéoporose. 2013 Disponible en ligne: https://facmed.univ- rennes1

S. Roux, New treatment targets in osteoporosis, Joint Bone Spine, vol.77, issue.3, pp.222-228, 2010.
DOI : 10.1016/j.jbspin.2010.02.004

T. Thomas, Medical treatment of postmenopausal osteoporosis, Rev Prat, vol.62, issue.2, pp.209-213, 2012.

R. Lindsay, W. Scheele, R. Neer, G. Pohl, S. Adami et al., Sustained Vertebral Fracture Risk Reduction After Withdrawal of Teriparatide in Postmenopausal Women With Osteoporosis, Archives of Internal Medicine, vol.164, issue.18, pp.2024-2030, 2004.
DOI : 10.1001/archinte.164.18.2024

N. Desmarais and J. Martineau, Le tériparatide (Forteo®) Québec Pharmacie, pp.513-520, 2005.

L. Merlouette, M. Adamski, H. Dinulescu, M. , L. Gall et al., Syndrome d???hypersensibilit?? m??dicamenteuse (DRESS) au ran??late de strontium, Annales de Dermatologie et de V??n??r??ologie, vol.138, issue.2, pp.124-128, 2011.
DOI : 10.1016/j.annder.2010.11.006

M. Vernejoul-de and P. Orcel, Nouvelles cibles thérapeutiques dans le traitement de l'ostéoporose. L'Actualité rhumatologique, 2009.

P. Kothawala, E. Badamgarav, S. Ryu, R. Miller, and R. Halbert, Systematic Review and Meta-analysis of Real-World Adherence to Drug Therapy for Osteoporosis, Mayo Clinic Proceedings, vol.82, issue.12, pp.1493-1501, 2007.
DOI : 10.1016/S0025-6196(11)61093-8

F. Cotté, P. Fardellone, F. Mercier, A. Gaudin, and C. Roux, Adherence to monthly and weekly oral bisphosphonates in women with osteoporosis, Osteoporosis International, vol.23, issue.1, pp.145-155, 2010.
DOI : 10.1007/BF03256676

B. Hamilton, K. Mccoy, and H. Taggart, Tolerability and compliance with risedronate in clinical practice, Osteoporosis International, vol.14, issue.3, pp.259-262, 2003.
DOI : 10.1136/hrt.80.5.430

M. Brookhart, J. Avorn, J. Katz, J. Finkelstein, M. Arnold et al., Gaps in Treatment Among Users of Osteoporosis Medications: The Dynamics of Noncompliance, The American Journal of Medicine, vol.120, issue.3, pp.251-256, 2007.
DOI : 10.1016/j.amjmed.2006.03.029

J. Curtis, A. Westfall, H. Cheng, K. Lyles, K. Saag et al., Benefit of Adherence With Bisphosphonates Depends on Age and Fracture Type: Results From an Analysis of 101,038 New Bisphosphonate Users, Journal of Bone and Mineral Research, vol.45, issue.9, pp.1435-1441, 2008.
DOI : 10.1359/jbmr.080418

V. Rabenda and J. Reginster, Overcoming problems with adherence to osteoporosis medication, Expert Review of Pharmacoeconomics & Outcomes Research, vol.82, issue.6, pp.677-689, 2010.
DOI : 10.1007/s00198-003-1544-7

J. Caro, K. Ishak, K. Huybrechts, G. Raggio, and C. Naujoks, The impact of compliance with osteoporosis therapy on fracture rates in actual practice, Osteoporosis International, vol.45, issue.12, pp.1003-1008, 2004.
DOI : 10.1007/s00198-004-1652-z

V. Rabenda, R. Mertens, V. Fabri, J. Vanoverloop, F. Sumkay et al., Adherence to bisphosphonates therapy and hip fracture risk in osteoporotic women, Osteoporosis International, vol.11, issue.Suppl 1, pp.811-818, 2008.
DOI : 10.1016/S0895-4356(96)00268-5

A. Warriner and J. Curtis, Adherence to osteoporosis treatments: room for improvement, Current Opinion in Rheumatology, vol.21, issue.4, pp.356-362, 2009.
DOI : 10.1097/BOR.0b013e32832c6aa4

T. Gleeson, M. Iversen, J. Avorn, A. Brookhart, J. Katz et al., Interventions to improve adherence and persistence with osteoporosis medications: a systematic literature review, Osteoporosis International, vol.21, issue.10, pp.2127-2134, 2009.
DOI : 10.1007/s00198-004-1597-2

E. Lespessailles, Education thérapeutique des patients dans l'ostéoporose. Correspondances en Métabolismes Hormones Diabètes et Nutrition, p.123, 2012.

J. Kanis, N. Burlet, C. Cooper, P. Delmas, J. Reginster et al., European guidance for the diagnosis and management of osteoporosis in postmenopausal women, Osteoporosis International, vol.18, issue.1, pp.399-428, 2008.
DOI : 10.3310/hta11070

K. Lyles, C. Colón-emeric, J. Magaziner, J. Adachi, C. Pieper et al., Zoledronic acid in reducing clinical fracture and mortality after hip fracture, N Engl J Med, vol.357, 2007.

M. Stevenson, M. Jones, D. Nigris, E. Brewer, N. Davis et al., A systematic review and economic evaluation of alendronate, etidronate, risedronate, raloxifene and teriparatide for the prevention and treatment of postmenopausal osteoporosis, Health Technology Assessment, vol.9, issue.22, pp.1-160, 2005.
DOI : 10.3310/hta9220

E. Barrett-connor, L. Mosca, P. Collins, M. Geiger, D. Grady et al., Effects of Raloxifene on Cardiovascular Events and Breast Cancer in Postmenopausal Women, New England Journal of Medicine, vol.355, issue.2, pp.125-137, 2006.
DOI : 10.1056/NEJMoa062462

J. Brown, R. Prince, C. Deal, R. Recker, D. Kiel et al., Comparison of the Effect of Denosumab and Alendronate on BMD and Biochemical Markers of Bone Turnover in Postmenopausal Women With Low Bone Mass: A Randomized, Blinded, Phase 3 Trial*, Journal of Bone and Mineral Research, vol.24, issue.1, pp.153-161, 2009.
DOI : 10.1359/JBMR.040305

P. Miller, M. Bolognese, E. Lewiecki, M. Mcclung, B. Ding et al., Effect of denosumab on bone density and turnover in postmenopausal women with low bone mass after long-term continued, discontinued, and restarting of therapy: A randomized blinded phase 2 clinical trial, Bone, vol.43, issue.2, pp.222-229, 2008.
DOI : 10.1016/j.bone.2008.04.007

S. Cummings, S. Martin, J. Mcclung, M. Siris, E. Eastell et al., Denosumab for Prevention of Fractures in Postmenopausal Women with Osteoporosis, New England Journal of Medicine, vol.361, issue.8, pp.756-765, 2009.
DOI : 10.1056/NEJMoa0809493

D. Kendler, C. Roux, C. Benhamou, J. Brown, M. Lillestol et al., Effects of denosumab on bone mineral density and bone turnover in postmenopausal women transitioning from alendronate therapy, Journal of Bone and Mineral Research, vol.17, issue.1, pp.72-81, 2010.
DOI : 10.1016/S0002-9440(10)64556-7

D. Kendler, M. Mcclung, N. Freemantle, M. Lillestol, A. Moffett et al., Adherence, preference, and satisfaction of postmenopausal women taking denosumab or alendronate, Osteoporosis International, vol.277, issue.Suppl 2, pp.1725-1735, 2011.
DOI : 10.1001/jama.277.1.63

R. Neer, C. Arnaud, J. Zanchetta, R. Prince, G. Gaich et al., Effect of Parathyroid Hormone (1-34) on Fractures and Bone Mineral Density in Postmenopausal Women with Osteoporosis, New England Journal of Medicine, vol.344, issue.19, pp.1434-1441, 2001.
DOI : 10.1056/NEJM200105103441904

A. Panico, G. Lupoli, F. Marciello, R. Lupoli, M. Cacciapuoti et al., Teriparatide vs. Alendronate as a treatment for osteoporosis: Changes in biochemical markers of bone turnover, BMD and quality of life, Medical Science Monitor, vol.17, issue.8, pp.442-448, 2011.
DOI : 10.12659/MSM.881905

P. Meunier, C. Roux, E. Seeman, S. Ortolani, J. Badurski et al., The Effects of Strontium Ranelate on the Risk of Vertebral Fracture in Women with Postmenopausal Osteoporosis, New England Journal of Medicine, vol.350, issue.5, pp.459-468, 2004.
DOI : 10.1056/NEJMoa022436

J. Reginster, E. Seeman, D. Vernejoul, M. Adami, S. Compston et al., Strontium Ranelate Reduces the Risk of Nonvertebral Fractures in Postmenopausal Women with Osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) Study, The Journal of Clinical Endocrinology & Metabolism, vol.90, issue.5, pp.2816-2822, 2005.
DOI : 10.1210/jc.2004-1774

O. Donnell, S. Cranney, A. Wells, G. Adachi, J. Reginster et al., Strontium ranelate for preventing and treating postmenopausal osteoporosis, Cochrane Database Syst Rev, issue.4, p.5326, 2006.

D. Torgerson and S. Bell-syer, Hormone Replacement Therapy and Prevention of Nonvertebral Fractures, JAMA, vol.285, issue.22, pp.2891-2897, 2001.
DOI : 10.1001/jama.285.22.2891

J. Eisman, H. Bone, D. Hosking, M. Mcclung, I. Reid et al., Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect, Journal of Bone and Mineral Research, vol.353, issue.(Suppl 1), pp.242-251, 2011.
DOI : 10.1056/NEJMoa050336

H. Bone, M. Mcclung, C. Roux, R. Recker, J. Eisman et al., Odanacatib, a Cathepsin-K Inhibitor for Osteoporosis: A Two-Year Study in Postmenopausal Women With Low Bone Density, Journal of Bone and Mineral Research, vol.25, issue.5, pp.937-947, 2010.
DOI : 10.1359/jbmr.091035

D. Padhi, G. Jang, B. Stouch, L. Fang, and E. Posvar, Single-dose, placebo-controlled, randomized study of AMG 785, a sclerostin monoclonal antibody, Journal of Bone and Mineral Research, vol.22, issue.1, pp.19-26, 2011.
DOI : 10.1359/jbmr.061101

G. Weryha, L. Nace, S. Petit, and L. Fiorani, La mise en place d'une filière de soins: exemple de l'ostéoporose. Toute l'ostéoporose dans « Osteoporoses.fr ». Disponible sur

D. Bliuc, N. Nguyen, V. Milch, T. Nguyen, J. Eisman et al., Mortality Risk Associated With Low-Trauma Osteoporotic Fracture and Subsequent Fracture in Men and Women, JAMA, vol.301, issue.5, pp.513-521, 2009.
DOI : 10.1001/jama.2009.50

R. Lindsay, S. Silverman, C. Cooper, D. Hanley, I. Barton et al., Risk of New Vertebral Fracture in the Year Following a Fracture, JAMA, vol.285, issue.3, pp.320-323, 2001.
DOI : 10.1001/jama.285.3.320

L. Langsetmo, D. Goltzman, C. Kovacs, J. Adachi, D. Hanley et al., Repeat Low-Trauma Fractures Occur Frequently Among Men and Women Who Have Osteopenic BMD, Journal of Bone and Mineral Research, vol.24, issue.9, pp.1515-1522, 2009.
DOI : 10.1359/jbmr.090319

URL : http://onlinelibrary.wiley.com/doi/10.1359/jbmr.090319/pdf

B. Edwards, A. Bunta, C. Simonelli, M. Bolander, and L. Fitzpatrick, Prior Fractures Are Common in Patients With Subsequent Hip Fractures, Clinical Orthopaedics and Related Research, vol.PAP, pp.226-230, 2007.
DOI : 10.1097/BLO.0b013e3180534269

A. Trombetti, F. Herrmann, P. Hoffmeyer, M. Schurch, J. Bonjour et al., Survival and Potential Years of Life Lost After Hip Fracture in Men and Age-matched Women, Osteoporosis International, vol.13, issue.9, pp.731-737, 2002.
DOI : 10.1007/s001980200100

M. Nevitt, B. Ettinger, D. Black, K. Stone, S. Jamal et al., The Association of Radiographically Detected Vertebral Fractures with Back Pain and Function: A Prospective Study, Annals of Internal Medicine, vol.128, issue.10
DOI : 10.7326/0003-4819-128-10-199805150-00001

C. Roux, J. Fechtenbaum, S. Kolta, R. Said-nahal, K. Briot et al., Prospective assessment of thoracic kyphosis in postmenopausal women with osteoporosis, Journal of Bone and Mineral Research, vol.31, issue.2, pp.362-368, 2010.
DOI : 10.1111/j.1532-5415.1997.tb01470.x

J. Fechtenbaum, C. Cropet, S. Kolta, S. Horlait, P. Orcel et al., The severity of vertebral fractures and health-related quality of life in osteoporotic postmenopausal women, Osteoporosis International, vol.63, issue.12, pp.2175-2179, 2005.
DOI : 10.1111/j.1532-5415.1997.tb01470.x

D. Kado, W. Browner, L. Palermo, M. Nevitt, H. Genant et al., Vertebral Fractures and Mortality in Older Women, Archives of Internal Medicine, vol.159, issue.11, pp.1215-1220, 1999.
DOI : 10.1001/archinte.159.11.1215

T. Jalava, S. Sarna, L. Pylkkänen, B. Mawer, J. Kanis et al., Association Between Vertebral Fracture and Increased Mortality in Osteoporotic Patients, Journal of Bone and Mineral Research, vol.15, issue.7, pp.1254-1260, 2003.
DOI : 10.1111/j.1532-5415.1995.tb07059.x

C. Pongchaiyakul, N. Nguyen, G. Jones, J. Center, J. Eisman et al., Asymptomatic Vertebral Deformity as a Major Risk Factor for Subsequent Fractures and Mortality: A Long-Term Prospective Study, Journal of Bone and Mineral Research, vol.156, issue.8, pp.1349-1355, 2005.
DOI : 10.1001/archinte.1996.00440130053006

R. Hasserius, M. Karlsson, B. Nilsson, R. , I. Johnell et al., Prevalent vertebral deformities predict increased mortality and increased fracture rate in both men and women: A 10-year population-based study of 598 individuals from the Swedish cohort in the European Vertebral Osteoporosis Study, Osteoporosis International, vol.14, issue.1, pp.61-68, 2003.
DOI : 10.1007/s00198-002-1316-9

S. Bouee, A. Lafuma, F. Fagnani, P. Meunier, and J. Reginster, Estimation of direct unit costs associated with non-vertebral osteoporotic fractures in five European countries, 1063?1072. 161. L'ostéoporose dans la communauté Européenne Disponible sur, 2002.
DOI : 10.7326/0003-4819-115-11-837

S. Jaglal, I. Weller, M. Mamdani, G. Hawker, H. Kreder et al., Population Trends in BMD Testing, Treatment, and Hip and Wrist Fracture Rates: Are the Hip Fracture Projections Wrong?, Journal of Bone and Mineral Research, vol.57, issue.S1, pp.898-905, 2005.
DOI : 10.2106/00004623-200008000-00001

L. Melton, S. Gabriel, C. Crowson, A. Tosteson, O. Johnell et al., Cost-equivalence of different osteoporotic fractures, Osteoporosis International, vol.14, issue.5, pp.383-388, 2003.
DOI : 10.1007/s00198-003-1385-4

B. Cortet, K. Briot, and M. Audran, L'ostéoporose masculine: savoir y penser, savoir la traiter, La Lettre du Rhumatologue. Décembre, vol.337, p.41, 2007.

P. Garnero, Biomarkers for Osteoporosis Management, Molecular Diagnosis & Therapy, vol.4, issue.9, pp.157-170, 2008.
DOI : 10.1210/jc.2006-1526

J. Stein, J. Lazewatsky, and A. Hochberg, Dual-energy X-ray bone densitometer incorporating an internal reference system, Radiology, vol.165, p.313, 1987.

T. Kelly, D. Slovik, D. Schoenfeld, and R. Neer, Dual Photon Absorptiometry of the Lumbar Spine*, The Journal of Clinical Endocrinology & Metabolism, vol.67, issue.4, pp.839-844, 1988.
DOI : 10.1210/jcem-67-4-839

P. Braillon, F. Duboeuf, M. Meary, P. Barret, P. Delmas et al., Mesure du contenu minéral osseux par radiographie digitale quantitative. Premiers résultats au niveau vertébral lombaire, Presse Méd, issue.18, pp.1062-1065, 1989.

H. Genant, K. Engelke, T. Fuerst, C. Glüer, S. Grampp et al., Noninvasive assessment of bone mineral and structure: State of the art, Journal of Bone and Mineral Research, vol.2, issue.P, pp.707-730, 1996.
DOI : 10.7326/0003-4819-117-1-1

. Ccam-en-ligne, Tarification détaillée Disponible sur

J. Kanis, E. Mccloskey, H. Johansson, A. Oden, L. Melton et al., A reference standard for the description of osteoporosis, Bone, vol.42, issue.3, pp.467-475, 2008.
DOI : 10.1016/j.bone.2007.11.001

M. Paggiosi, C. Glueer, C. Roux, D. Reid, D. Felsenberg et al., International variation in proximal femur bone mineral density, Osteoporosis International, vol.18, issue.249, pp.721-729, 2011.
DOI : 10.1007/s00198-006-0245-4

W. Leslie, R. Adler, G. El-hajj-fuleihan, A. Hodsman, D. Kendler et al., Application of the 1994 WHO Classification to Populations Other Than Postmenopausal Caucasian Women: The 2005 ISCD Official Positions, Journal of Clinical Densitometry, vol.9, issue.1, pp.22-30, 2006.
DOI : 10.1016/j.jocd.2006.05.004

P. Ravaud, J. Reny, B. Giraudeau, R. Porcher, M. Dougados et al., Individual Smallest Detectable Difference in Bone Mineral Density Measurements, Journal of Bone and Mineral Research, vol.52, issue.8, pp.1449-1456, 1999.
DOI : 10.7326/0003-4819-104-6-817

S. Berry, E. Samelson, M. Pencina, R. Mclean, L. Cupples et al., Repeat Bone Mineral Density Screening and Prediction of Hip and Major Osteoporotic Fracture, JAMA, vol.310, issue.12, pp.3101256-1262, 2013.
DOI : 10.1001/jama.2013.277817

R. Levasseur, J. Sabatier, C. Guilcher, G. Guaydier-souquières, V. Costentin-pignol et al., Medical management of??patients over 50??years admitted to??orthopedic surgery for??low-energy fracture, Joint Bone Spine, vol.74, issue.2, pp.160-165, 2007.
DOI : 10.1016/j.jbspin.2006.03.003

M. Rancier, La filière de soins Qualité de l'os en Lorraine (QOL): les déterminants de la santé osseuse dans la cohorte de la filière de soins QOL, Thèse: Médecine spécialisée, 2007.

G. Albrand, F. Munoz, E. Sornay-rendu, F. Duboeuf, and P. Delmas, Independent predictors of all osteoporosis-related fractures in healthy postmenopausal women: The OFELY Study, Bone, vol.32, issue.1, pp.78-85, 2003.
DOI : 10.1016/S8756-3282(02)00919-5

R. Macinnis, C. Cassar, C. Nowson, L. Paton, L. Flicker et al., Determinants of Bone Density in 30- to 65-Year-Old Women: A Co-Twin Study, Journal of Bone and Mineral Research, vol.13, issue.9, pp.1650-1656, 2003.
DOI : 10.1093/oxfordjournals.aje.a009361

R. Lindsay, F. Cosman, B. Herrington, and S. Himmelstein, Bone mass and body composition in normal women, Journal of Bone and Mineral Research, vol.5, issue.1, pp.55-63, 1992.
DOI : 10.1159/000401993

J. Reseland, U. Syversen, I. Bakke, G. Qvigstad, L. Eide et al., Leptin Is Expressed in and Secreted from Primary Cultures of Human Osteoblasts and Promotes Bone Mineralization, Journal of Bone and Mineral Research, vol.63, issue.Suppl 3, pp.1426-1433, 2001.
DOI : 10.3181/00379727-80-19661

M. Hannan, K. Tucker, B. Dawson-hughes, L. Cupples, D. Felson et al., Effect of Dietary Protein on Bone Loss in Elderly Men and Women: The Framingham Osteoporosis Study, Journal of Bone and Mineral Research, vol.35, issue.Suppl 3, pp.2504-2512, 2000.
DOI : 10.7326/0003-4819-128-10-199805150-00002

A. Goulding, R. Taylor, I. Jones, K. Mcauley, P. Manning et al., Overweight and obese children have low bone mass and area for their weight, International Journal of Obesity, vol.22, issue.Suppl 1, pp.627-632, 2000.
DOI : 10.1016/S8756-3282(98)00046-5

J. Cao, Effects of obesity on bone metabolism, Journal of Orthopaedic Surgery and Research, vol.6, issue.1, p.30, 2011.
DOI : 10.1016/S8756-3282(02)00864-5

A. Tromp, M. Ooms, C. Popp-snijders, J. Roos, and P. Lips, Predictors of Fractures in Elderly Women, Osteoporosis International, vol.11, issue.2, pp.134-140, 2000.
DOI : 10.1007/PL00004174

A. Unnanuntana, B. Gladnick, E. Donnelly, and J. Lane, The Assessment of Fracture Risk, The Journal of Bone and Joint Surgery-American Volume, vol.92, issue.3, pp.743-753, 2010.
DOI : 10.2106/JBJS.I.00919

L. Melton, S. Khosla, E. Atkinson, O. Fallon, W. Riggs et al., Relationship of Bone Turnover to Bone Density and Fractures, Journal of Bone and Mineral Research, vol.4, issue.Suppl 1, pp.1083-1091, 1997.
DOI : 10.1136/bmj.312.7029.482

S. Roux, F. Cabana, N. Carrier, M. Beaulieu, P. April et al., The World Health Organization Fracture Risk Assessment Tool (FRAX) Underestimates Incident and Recurrent Fractures in Consecutive Patients With Fragility Fractures, The Journal of Clinical Endocrinology & Metabolism, vol.99, issue.7, 2014.
DOI : 10.1210/jc.2013-4507

E. Sornay-rendu, F. Munoz, P. Delmas, and R. Chapurlat, The FRAX tool in French women: How well does it describe the real incidence of fracture in the OFELY cohort, Journal of Bone and Mineral Research, vol.21, issue.10, pp.2101-2107, 2010.
DOI : 10.1002/jbmr.106

F. Trémollières, J. Pouilles, T. Cochet, C. Cohade, and C. Ribot, Évaluation du risque fracturaire en début de ménopause par le score FRAX. 22e Congrès français de rhumatologie Disponible sur: http://sfr.larhumatologie.fr/ModuleEventPublic/viewPresentation.phtml?, pp.2-2009, 2009.

J. Pouilles, F. Trémollières, P. Dargent-molina, N. Drewniak, J. Laparra et al., Evaluation du risque fracturaire et score FRAX en début de ménopause: données de la cohorte MENOS, 2009.

H. Castel, D. Bonneh, M. Sherf, and Y. Liel, Awareness of Osteoporosis and Compliance with Management Guidelines in Patients with Newly Diagnosed Low-Impact Fractures, Osteoporosis International, vol.12, issue.7, pp.559-564, 2001.
DOI : 10.1007/s001980170077

C. Roux, Valeur du FRAX chez les femmes ostéoporotiques traitées en médecine générale. 22e Congrès français de rhumatologie, 2009.

V. Elliot-gibson, E. Bogoch, S. Jamal, and D. Beaton, Practice patterns in the diagnosis and treatment of osteoporosis after a fragility fracture: a systematic review, Osteoporosis International, vol.15, issue.10, pp.767-778, 2004.
DOI : 10.1007/s00198-004-1675-5

H. Kamel, Secondary Prevention of Hip Fractures Among the Hospitalized Elderly, JCR: Journal of Clinical Rheumatology, vol.11, issue.2, pp.68-71, 2005.
DOI : 10.1097/01.rhu.0000158545.26370.5c

A. Papaioannou, L. Giangregorio, B. Kvern, P. Boulos, G. Ioannidis et al., The osteoporosis care gap in Canada, BMC Musculoskeletal Disorders, vol.159, issue.1, p.11, 2004.
DOI : 10.1056/NEJM199304083281407

S. Malochet-guinamand, N. Chalard, C. Billault, N. Breuil, J. Ristori et al., Osteoporosis treatment in postmenopausal women after peripheral fractures: impact of information to general practitioners, Joint Bone Spine, vol.72, issue.6, pp.562-566, 2005.
DOI : 10.1016/j.jbspin.2004.03.014

C. Kimber and K. Grimmer-somers, Evaluation of current practice: compliance with osteoporosis clinical guidelines in an outpatient fracture clinic, Australian Health Review, vol.32, issue.1, pp.34-43, 2008.
DOI : 10.1071/AH080034

T. Thomas, J. Feron, P. Delmas, J. Kaufman, L. Tosi et al., Prise en charge optimale des patients pr??sentant une fracture de fragilit??, Revue de Chirurgie Orthop??dique et R??paratrice de l'Appareil Moteur, vol.92, issue.2, pp.165-174, 2006.
DOI : 10.1016/S0035-1040(06)75702-6